Biology of Tumor Micrometastasis
Journal of Hematotherapy · 1996-10 · 5 (5) · 525-535
DOI: 10.1089/scd.1.1996.5.525 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Hematotherapy, 1996-10. Verfasst von A Ahmad und 1 weiteren Autor:innen. Beteiligte Einrichtung: Richard Dimbleby Department of Cancer Research/ICRF, Rayne Institute, UMDS, St. Thomas' Hospital, London, UK. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 123 Literaturangaben.
Abstract (Originalsprache)
Metastasis is the major cause of death in cancer patients. Our understanding of the molecular genetic and biologic events that contribute to tumor cell dissemination has increased considerably over the last decade. It is clear that close anatomic and temporal cooperation between cellular adhesion molecules, extracellular matrix-degrading proteases, and tumor vascularization is an essential component of the metastatic behavior of cancer cells. With this improved understanding have come novel antimetastatic therapies targeting distinct molecules and steps in the metastatic cascade. Here, we review the role of matrix-degrading enzymes, changes in cellular adhesive capacity, and tumor angiogenesis during cancer spread.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Richard Dimbleby Department of Cancer Research/ICRF, Rayne Institute, UMDS, St. Thomas' Hospital, London, UK.
Zitieren
APA
Ahmad, A., & Hart, I. R. (1996). Biology of Tumor Micrometastasis. Journal of Hematotherapy, 5(5), 525-535. https://doi.org/10.1089/scd.1.1996.5.525
Vancouver
Ahmad A, Hart IR. Biology of Tumor Micrometastasis. Journal of Hematotherapy. 1996;5(5):525-535. doi:10.1089/scd.1.1996.5.525
BibTeX
@article{Ahmad1996,
author = {Ahmad, A and Hart, I R},
title = {Biology of Tumor Micrometastasis},
journal = {Journal of Hematotherapy},
year = {1996},
volume = {5},
number = {5},
pages = {525--535},
doi = {10.1089/scd.1.1996.5.525}
}
EUVIMED